Ordering
Available Variants5 mg
CHJ.93954-5mg
Price
€79.20
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHJ.93954-5mg | €79.20 |
≥98% (HPLC)
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C23H27ClN4O3 |
|---|---|
| CAS Number | 476159-98-5 |
| Molecular Weight | 442.94 |
| UNSPSC Code | 12352200 |
| NACRES | NA.77 |
| MDL number | MFCD19690925 |
| Assay | ≥98% (HPLC) |
| Form | powder |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
AZM475271, also known by its CAS number 476159-98-5, is a synthetic compound that has been investigated for its potential therapeutic applications. This molecule exhibits a unique mechanism of action, which has sparked interest in its possible use as a medicinal agent. Research has focused on the compounds ability to interact with specific biological targets, leading to a range of potential effects. Studies have explored the compounds pharmacokinetic and pharmacodynamic properties, including its absorption, distribution, metabolism, and excretion. Additionally, investigations have examined the compounds efficacy and safety profile, with a view to determining its potential as a treatment for various diseases. Further research is needed to fully elucidate the properties and potential uses of AZM475271, but initial findings suggest that it may have significant therapeutic potential.
